Enacts provisions relating to insurance coverage of health care services
Second Read and Referred S Insurance and Banking Committee
Email me when SB 846 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SB 846. By continuing you agree to the Terms and Privacy Policy.
Summary
The measure adds new rules that forbid health insurers and pharmacy‑benefit managers from restricting or charging extra for medically necessary clinician‑administered drugs, biosimilars and 340B drugs. It also limits when insurers can require prior authorizations, tying the requirement to a provider’s past approval rates and creating exemptions for high‑performing hospitals. The bill failed to pass and was referred to the Senate Insurance and Banking Committee.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SB 846
3 free questions a day, no accountHistory
- Second Read and Referred S Insurance and Banking Committee
- S First Read
- Prefiled
Sponsors
- Justin Brown (R) · sponsor
- Brown (16), Justin
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SB 846 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 846 freeOr ask your AI assistant about SB 846 directly:
Add to Claude, ChatGPT or Cursor